Neurotrophic factors and Alzheimer's disease: are we focusing on the wrong molecule?
about
The effects of aging on the BTBR mouse model of autism spectrum disorder.Small molecule activators of the Trk receptors for neuroprotectionDecreased serum brain-derived neurotrophic factor levels in elderly korean with dementiaNeurotrophic effect of a novel TrkB agonist on retinal ganglion cells.Therapeutic perspectives of drugs targeting Toll-like receptors based on immune physiopathology theory of Alzheimer's disease.A selective histone deacetylase-6 inhibitor improves BDNF trafficking in hippocampal neurons from Mecp2 knockout mice: implications for Rett syndrome.Role of the central cholinergic system in the therapeutics of schizophrenia.Association of rs6265 and rs2030324 polymorphisms in brain-derived neurotrophic factor gene with Alzheimer's disease: a meta-analysis.Oral consumption of α-linolenic acid increases serum BDNF levels in healthy adult humans.Brain-derived neurotrophic factor ameliorates learning deficits in a rat model of Alzheimer's disease induced by aβ1-42Estrogen and brain-derived neurotrophic factor (BDNF) in hippocampus: complexity of steroid hormone-growth factor interactions in the adult CNS.Re-engineering a neuroprotective, clinical drug as a procognitive agent with high in vivo potency and with GABAA potentiating activity for use in dementia.Age-related neurodegeneration and memory loss in down syndrome.Potential drugs and methods for preventing or delaying the progression of Huntington's disease.Altered balance of proteolytic isoforms of pro-brain-derived neurotrophic factor in autismDevelopment and evaluation of a multiplexed mass spectrometry based assay for measuring candidate peptide biomarkers in Alzheimer's Disease Neuroimaging Initiative (ADNI) CSF.The impact of Bdnf gene deficiency to the memory impairment and brain pathology of APPswe/PS1dE9 mouse model of Alzheimer's disease.ProBDNF and its receptors are upregulated in glioma and inhibit the growth of glioma cells in vitro.The differences in neuroprotective efficacy of progesterone and medroxyprogesterone acetate correlate with their effects on brain-derived neurotrophic factor expression.Gene therapy in Alzheimer's disease - potential for disease modificationThe neurotrophins and their role in Alzheimer's disease.Multiple approaches to investigate the transport and activity-dependent release of BDNF and their application in neurogenetic disorders.Filling the void: a role for exercise induced BDNF and brain amyloid precursor protein processing.Potential for Stem Cells Therapy in Alzheimer's Disease: Do Neurotrophic Factors Play Critical Role?Integral Characterization of Defective BDNF/TrkB Signalling in Neurological and Psychiatric Disorders Leads the Way to New Therapies.The BDNF val-66-met Polymorphism Affects Neuronal Morphology and Synaptic Transmission in Cultured Hippocampal Neurons from Rett Syndrome Mice.Increased Hippocampal ProBDNF Contributes to Memory Impairments in Aged Mice.Distribution of VGF peptides in the human cortex and their selective changes in Parkinson's and Alzheimer's diseases.
P2860
Q30586703-8332073E-BACF-47DF-9456-ED08CD0A05C7Q33393895-23F2C353-5F14-485D-BA36-7C856F588FF7Q33600342-60BDDAF2-2A06-48D2-A384-83F61E1507A9Q33845125-86858680-A8FA-4079-9FEC-21FD3816E8BBQ34064026-65D3A715-4CF9-4342-B1D8-803C2E4775D4Q34410663-071AA7E5-AC51-405B-9924-E70E9A97F484Q34608625-5A628E02-69DC-403B-9FF8-D2BA77111D45Q35147885-B2123B23-FD89-4993-85F0-D08036694429Q35159339-04F668D5-0435-489C-821E-B891BE8BC44EQ35303354-B210AA4A-DF9A-4F80-9F74-E7F71C915736Q35603915-B349D130-E538-41E0-966C-9DBD670BE6DFQ35813037-9888A8B2-9671-4423-AA4E-FAEE71131EBCQ35867093-5CBE6F88-E35D-4F03-804B-89D18BF710BCQ36142706-8C63B685-9029-43F4-BC90-11CA3CE6F2D6Q36164551-A70F2E71-F2F9-4D31-864D-70DC0345AC51Q36539376-CE827C79-1EAF-4146-ABAE-4D9B132CF38DQ36980971-1562B3D6-2F40-42B2-96FF-A0A73496CCE0Q37021547-CE797870-F1EE-4F46-9714-0568A754DFF0Q37244686-637C550F-3957-43DD-8BE9-21722317416EQ37295252-46AD6040-B106-4F6E-B5CC-03D5E3FC6593Q38015342-1547E117-06E7-48A8-BB01-82590DD24090Q38020487-18AADE9F-D0EC-471A-B5E4-72A490C293FFQ38641542-AA29D236-FA1C-451C-AC7C-C3741CF09614Q38772566-45060743-AB45-418F-83D3-069EEB958B74Q39109344-8D27207D-3E6F-4090-8579-9C6AFBA91609Q40999723-CAF087A7-4A98-43DC-994D-3EEAC7AB655BQ41605680-98307F3F-477C-48C1-9CF6-1C225D360E4EQ46628274-B6B51EA0-BE36-4496-9B03-9C33C6857732
P2860
Neurotrophic factors and Alzheimer's disease: are we focusing on the wrong molecule?
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Neurotrophic factors and Alzheimer's disease: are we focusing on the wrong molecule?
@en
Neurotrophic factors and Alzheimer's disease: are we focusing on the wrong molecule?
@nl
type
label
Neurotrophic factors and Alzheimer's disease: are we focusing on the wrong molecule?
@en
Neurotrophic factors and Alzheimer's disease: are we focusing on the wrong molecule?
@nl
prefLabel
Neurotrophic factors and Alzheimer's disease: are we focusing on the wrong molecule?
@en
Neurotrophic factors and Alzheimer's disease: are we focusing on the wrong molecule?
@nl
P2093
P1476
Neurotrophic factors and Alzheimer's disease: are we focusing on the wrong molecule?
@en
P2093
B Michalski
M Fahnestock
P304
P356
10.1007/978-3-7091-6139-5_22
P577
2002-01-01T00:00:00Z